SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMRA (Biomerica) -- Ignore unavailable to you. Want to Upgrade?


To: Radam who wrote (58)2/20/1998 10:56:00 AM
From: Radam  Read Replies (1) | Respond to of 170
 
BMRA has not publicly reported their last quarter's (ending Nov. 30), at least I have not been able to find a press release anywhere. They did file their 10Q with the SEC; I've copied some of it below. This table is for the first 6 months of the fiscal year. For the quarter ended Nov. 30, BMRA earned only a penny a share, down from .03. For a complete reckoning go to the SEC's home page and search the Edgar database for BMRA's complete 10Q filed on January 14th. I wonder why BMRA chose not to comment in a press release?

PART I - FINANCIAL INFORMATION
SUMMARIZED FINANCIAL INFORMATION
<TABLE>
BIOMERICA, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

<CAPTION>
Six Months Ended
November 30,
1997 1996
------------- ------------- --------------

Net Sales............................. $ 4,856,966 $ 4,553,025 $
Cost of sales ....................... 2,870,085 2,595,976
-------------- ------------- ------------- ------------

Gross profit ........................ 1,986,881 1,957,049
-------------- ------------- ------------- ------------

Operating Expenses:

Selling, general and administrative . 1,583,714 1,551,104
Research and development ............ 275,166 124,995
-------------- ------------- -------------- -------------

1,858,880 1,676,099
-------------- ------------- ------------- -------------

Other Expense (income):
Interest expense .................... 17,074 31,879
Other (income), net ................. (91,826) (25,579)
-------------- ------------- ------------- -------------

Gain before minority interest in
net profits of consolidated
subsidiaries and income taxes ....... 202,753 274,650

Minority interest in net (profits)
of consolidated subsidiaries ........ (20,642) (25,918)
-------------- ------------ ------------ ------------

Income before taxes ................. 182,111 248,732
Income taxes ........................ 16,390 17,847
-------------- ------------- --------------

NET INCOME ......................... $ 165,721 $ 230,885 $
============== =============
Net income per share.................. $ .04 $ .07
============== =============

Weighted average
shares outstanding .................. 3,922,969 3,526,469